» Authors » Benedikt Huttner

Benedikt Huttner

Explore the profile of Benedikt Huttner including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 86
Citations 1432
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Funiciello E, Lorenzetti G, Cook A, Goelen J, Moore C, Campbell S, et al.
J Antimicrob Chemother . 2024 Oct; 79(12):3063-3077. PMID: 39422368
Introduction: Quality indicators (QIs) are widely used tools for antibiotic stewardship programmes. The Access, Watch, Reserve (AWaRe) system has been developed by the WHO to classify antibiotics based on their...
2.
Piggott T, Moja L, Huttner B, Okwen P, Raviglione M, Kredo T, et al.
Bull World Health Organ . 2024 Sep; 102(10):722-729. PMID: 39318894
The first version of the contained 186 medicines in 1977 and has evolved to include 502 medicines in 2023. Over time, different articles criticized the methods and process for decisions;...
3.
McMullan B, Kim H, Alastruey-Izquierdo A, Tacconelli E, Dao A, Oladele R, et al.
Med Mycol . 2024 Jun; 62(6). PMID: 38935910
This systematic review evaluates the current global impact of invasive infections caused by Pneumocystis jirovecii (principally pneumonia: PJP), and was carried out to inform the World Health Organization Fungal Priority...
4.
Bamford A, Masini T, Williams P, Sharland M, Gigante V, Dixit D, et al.
Lancet Child Adolesc Health . 2024 Apr; 8(6):456-466. PMID: 38648808
Children and neonates are highly vulnerable to the impact of antimicrobial resistance. Substantial barriers are faced in relation to research and development of antibacterial agents for use in neonates, children,...
5.
Moja L, Zanichelli V, Mertz D, Gandra S, Cappello B, Cooke G, et al.
Clin Microbiol Infect . 2024 Feb; 30 Suppl 2:S1-S51. PMID: 38342438
The WHO Model List of Essential Medicines (EML) prioritizes medicines that have significant global public health value. The EML can also deliver important messages on appropriate medicine use. Since 2017,...
6.
Piggott T, Moja L, Garcia C, Akl E, Banzi R, Huttner B, et al.
PLOS Glob Public Health . 2024 Jan; 4(1):e0002723. PMID: 38206901
Essential medicine lists (EMLs) are important medicine prioritization tools used by the World Health Organization (WHO) EML and over 130 countries. The criteria used by WHO's Expert Committee on the...
7.
Costa E, Moja L, Wirtz V, van den Ham H, Huttner B, Magrini N, et al.
Bull World Health Organ . 2024 Jan; 102(1):22-31. PMID: 38164340
Objective: We evaluated the uptake of medicines licensed as orphan drugs by the United States Food and Drug Administration (FDA) or European Medicines Agency (EMA) into the and the from...
8.
Piggott T, Moja L, Akl E, Lavis J, Cooke G, Kredo T, et al.
J Clin Epidemiol . 2022 Dec; 154:146-155. PMID: 36584732
Background And Objectives: The World Health Organization Model List of Essential Medicines has led to at least 137 national lists. Essential medicines should be grounded in evidence-based guideline recommendations and...
9.
Sharland M, Zanichelli V, Ombajo L, Bazira J, Cappello B, Chitatanga R, et al.
Clin Microbiol Infect . 2022 Aug; 28(12):1533-1535. PMID: 36007869
Antibiotics are often prescribed inappropriately, either when they are not necessary or with an unnecessarily broad spectrum of activity. AWaRe (AccessWatchReserve) is a system developed by WHO to classify antibiotics...
10.
Sulis G, Sayood S, Katukoori S, Bollam N, George I, Yaeger L, et al.
Clin Microbiol Infect . 2022 Mar; 28(9):1193-1202. PMID: 35339675
Background: Antibiotic use drives antibiotic resistance. Objectives: To systematically review the literature and estimate associations between prior exposure to antibiotics across World Health Organization's (WHO) AWaRe categories (Access, Watch, Reserve)...